Connections between prenatal exposure to endocrine-disrupting chemicals and the growth patterns of children’s BMI.
Amgen nabs FDA approval for first Soliris interchangeable biosimilar
The FDA approved Amgen’s monoclonal antibody Bkemv as the first interchangeable biosimilar for Alexion’s blockbuster Soliris to treat two types of rare blood diseases, the